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 The use of plasmid deoxyribonucleic acid (pDNA) in the emerging gene therapy 
and nucleic acid based biopharmaceuticals requires pure pDNA in large quantities, so it 
calls for a production of safe pDNA on large scale. 
The main achievement of this experimental research was to find alternative 
matrices to pDNA purification, regarding to economical, simple and efficacy features. 
The choice of cellulose is due their easy and cheap obtainment and their relatively 
trouble-free modification; sepharose was mainly to compare results. Were tested two 
types of adsorption: hydrophobic interaction (is the most common and is easy and low-
cost to perform) and anion-exchange (is also easy and low-cost and, generally, is more 
effective). The method of choice was batch adsorption, because of possible problems 
such as column chromatography high back pressure and poor capacity pDNA binding, 
furthermore is an easier method to scale-up. 
Through hydrophobic interaction was possible to adsorb up to 0,4 μg of pDNA 
per mg of cellulose microfibers gel, with ammonium sulfate 3,0 M, an enormous 
concentration of salt, so was concluded that the hydrophobic interaction is due to 
amount of salt. Through anion-exchange batch, the adorption was up to 2,5 μg of pDNA 
per mg of gel. Comparing with sepharose based-matrix (adorption was up to 0,7 μg of 
pDNA per mg of gel), cellulose microfibers are a better support, probably due the 
surface area expose to ligands. Factors that can be improved in these alternative 
matrices to pDNA purification experiments are: an increase of pDNA initial 
concentrations, a decrease of gel mass and, if possible, an increase of matrix surface 
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 O uso de ácido desoxirribonucleico plasmídico (pDNA) na emergente terapia 
génica e em biofármacos requer pDNA puro em grandes quantidades, portanto há uma 
necessidade de produção de pDNA seguro em larga escala. 
 O principal objectivo desta investigação experimental foi encontrar matrizes 
alternativas para purificação de pDNA, dando importância a recursos económicos, 
simples e eficazes. A escolha da celulose foi devida à sua obtenção fácil e económica e 
modificação sem grandes problemas; a escolha da sefarose foi, principalmente, para 
estabelecer termo de comparação. Foram testados dois tipos de adsorção: interacção 
hidrofóbica (é a mais comum e a mais fácil e económica) e troca-aniónica (também é 
fácil e económica e, no geral, é mais eficaz). O método de escolha foi adsorção em 
batch, devido a possíveis problemas inerentes a cromatografia em coluna, como elevada 
back pressure e baixa capacidade de ligação do pDNA, para além disso, é um método 
mais fácil para larga escala. 
 Por interacção hidrofóbica, foi possível adsorver até 0,4 μg de pDNA por mg de 
gel de microfibras de celulose, com sulfato de amónia 3,0 M, uma concentração enorme 
de sal, portanto, concluiu-se que esta interacção hidrofóbica é por causa do sal. Através 
de troca-aniónica, foi possível adsorver até 2,5 μg de pDNA por mg de gel. 
Comparando com a matriz de sefarose (adsorção até 0,7 μg de pDNA por mg de gel), a 
matriz de celulose é um suporte melhor, provavelmente devido à área da superfície 
exposta aos ligandos. Factores que podem ser melhorados nestes ensaios com este tipo 
de matrizes para purificação de pDNA são: um aumento da concentração inicial de 
pDNA, uma redução da massa do gel e, se possível, um aumento da área de superfície 




Palavras-chave: adsorção em batch, interacção hidrofóbica, microfibras de celulose, modificação da 
superfície, troca-aniónica, partículas de sefarose e purificação de pDNA. 
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 The use of plasmid deoxyribonucleic acid (pDNA) in the emerging gene therapy 
and nucleic acid based biopharmaceuticals requires pure pDNA in large quantities, so it 
calls for a production of safe pDNA on large scale. 
There are a great number of kit-based DNA purification techniques and 
conventional chromatography media for adsorption of pDNA, but large scale effective 
pDNA purification remains a biotechnological challenge, as chromatographic processes 
normally offer low dynamic binding capacities and poor productivity. Consequently, 
there is an urgent need for high selectivity, high capacity and high productivity 
purification methods for pDNA. 
Previous work reports about rapid and selective adsorption of DNA to 
submicron sized polymeric particles in high capacity and recovery (Kim and Rha, 
1989). Based on that, there is interest in investigate polymeric structures that can be 
modified and applied to plasmid adsorption, in this particular case, cellulose microfibers 




Chapter one focuses in fundamental concepts and background about plasmid 
DNA and its major applications, gene therapy and DNA vaccination. 
A general view about plasmids purification is given in Chapter two, as well as a 
description about the purification methods based on hydrophobic interactions and 
anion-exchange, which are the techniques used in this experimental project. 
Notions about cellulose fibers, PVA nanofibers (especially those produced by 
electrospinning) and stationary phases in general are given in Chapter three. 
Research aim and main questions beneath this investigation project are 
enumerated at Chapter four. 
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Chapter five describes the obtainment of plasmids that were used in the 
adsorptions studies, with a methodology based on a commercial kit. 
Chapter six explains how the several gel matrices were produced and shows the 
major results. 
At Chapter seven, are the adsorptions experiments procedure and the 
intermediate results. 
In Chapter eight, the obtained results are analyzed and clarified. 
At the end, the study is concluded and future research suggestions related with 

















CHAPTER 1. PLASMID DNA SIGNIFICANCE AND 
APPLICATIONS 
 
Plasmid earned an increasing attention as a biotherapeutic in gene therapy and 
DNA vaccination. However, a full treatment require milligram quantities of plasmid 
DNA and that's why is important to developed a cost effective large-scale process for 
the production of plasmid DNA, which should be capable of providing the product 
plasmid at required levels of product purity, potency, efficacy and safety (Deshmukh 
and Lali, 2005; Ferreira et al, 2000). 
 
 
1.1. PLASMID DNA 
 
By definition, plasmids are circular, covalently closed, double stranded DNA 
molecules, very large, when compared with proteins, and comprise approximately 1% 
of the total content of the host bacterial cell (table 1) (Prazeres et al, 1999). 
 






Genomic DNA 1% 




Each pDNA molecule strand is a linear polymer of deoxyribonucleotides linked 
by phosphodiester bonds, which are negatively charged for pH > 4. The two strands are 
winding in an anti-parallel way, around each other and around a common axis that gives 
them the typical right handed double helix structure, stabilized by hydrogen bonds 
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between adenine-thymine (AT) and guanine-cytosine (GC) base pairs and by stacking 
forces. Double-helix inside is extremely hydrophobic, because of the aromatic bases 
close packing. The pDNA helix axis can also coil itself, forming supercoiled pDNA, 
which is the plasmid configuration that matters to gene therapy and DNA vaccine 
applications. The other forms of pDNA molecules, besides supercoiled (sc) and open 
circular (oc), that could be found in cell lysate are: linear (resulting from chemical or 
enzymatic cleavage of the phosphodiester bonds), denatured (resulting from hydrogen 
bonding disruption between complementary strands) or oligomeric (resulting from 
homologous recombination) (Sinden, 1994; Summers, 1996). 
 
 
1.2. GENE THERAPY 
 
Gene therapy is an approach for tackling diseases at the genetic level by, for 
example, substitution of a defective gene with the correct nucleic acid sequence in order 
to restore normal cellular function, through delivery of one or more functional genes 
into a patient (Anderson, 1992; Crystal, 1995). 
 One of the major challenges in gene therapy is to get safe vectors able of 
transporting genes efficiently into the target cells (Legendre et al, 1996). 
In the past, viral vectors (examples at table 2) have been used to exploit their 
natural ability to infect cells, but this use was limited because of safety and regulatory 
concerns, that include immunogenicity, toxicity and the oncogenes and tumor 
suppressor genes possible activation/deactivation (Anderson, 1998; Ferreira et al, 1998; 
Fox, 1999; Luo and Saltzman 2000). 
 
TABLE 2 VIRAL SYSTEMS THAT HAVE BEEN DEVELOPED FOR GENE THERAPY (ADAPTED FROM 
DARBY AND HINE, 2005). 
Modified Viral System Reference 
Adenoviral 




Poxviruses Robinson et al, 1999 




 The use of viral vectors have resulted in adverse reactions in patients, with 
several deaths reported (Fox, 1999). Also, since 2003, all retroviral-based gene therapy 
to insert genes into blood stem cells clinical experiments are suspended by Food and 
Drug Administration (FDA) (FDA, 2003). 
Plasmids vectors are considered to be a safer option, free from specific safety 
concerns viruses-associated and, in general, simpler to develop (Scherman, 2001). 
However, they are less effective than viral vectors. It is estimated that only one in every 
1000 plasmid molecules presented to the cells reaches the nucleus and is expressed, 
with full treatments requiring milligram quantities of plasmid DNA (Crystal, 1995; Luo 
and Saltzman, 2000). 
 
 
1.3. DNA VACCINATION 
 
Plasmid DNA has been also used as a new and safer generation of vaccines, 
expressing specific antigens on cell membranes, stimulating and enhancing the immune 
system‟s response and memory (Tighe et al, 1998). 
It is believed that pDNA vaccination pathway is similar to the natural 
intracellular pathogen gene expression pathways, which leads to cellular and humoral 
responses, and therefore can achieve the same protection afforded by virulent or 
attenuated infectious microorganisms (figure 1) (Prather et al, 2003). 
However, similarly to what happens in gene therapy, DNA vaccines are not 
effective enough (compared with the viral). In small animals, such as mice, strong 
immune responses can be induced, but in larger animals (so, the same happens in 
humans) multiple immunizations of high DNA doses are often required to achieve 




FIGURE 1 IMMUNE RESPONSE TO PLASMID DNA VACCINATION (ADAPTED FROM PRATHER ET AL, 















CHAPTER 2. PLASMID DNA PURIFICATION  
 
2.1. GENERAL PROCEDURE 
 
Plasmid DNA production can be divide in two stages: upstream processing and 
downstream processing, however these stages of process development are integrated 
and must not be approached on an individual basis. So, pDNA production usually 
begins with the construction and selection of appropriate expression vectors and 
production microorganisms, followed by the selection and optimization of the 
fermentation conditions, cell growth, and finally the isolation and purification steps 
(Kelly and Hatton, 1991). 
Upstream processing stage objectives are the design, selection and optimization 
of appropriate plasmid vectors, production microorganism strains and growth 
conditions, in order to enable the production of large quantities of stable supercoiled 
plasmid DNA. Safety and potency demands of gene-therapy vectors, and the inherent 
requirements for large-scale production and purification of the plasmid vector should be 
considered at these stages (Prazeres et al, 1999; Schleef, 1999). Fermentation is 
followed by a sequence of purification steps, which eliminate impurities, to obtain a 
final plasmid DNA preparation that fulfills the approval specifications – Table 3 
(Ferreira 2000). 
Within downstream stage are some steps that could be identified as: cell harvest, 
cell lysis, cell debris removal, affinity precipitation, adsorption, and buffer 
exchange/concentration (figure 2 illustrate those steps), but is not that straightforward. 
There are several difficulties associated with direct scale-up of some common 
laboratory procedures. 
Current purification methods are kits marketed by commercial companies that 
take advantage of techniques such as alkaline lysis and the use of disposable 
chromatography columns. However, these purification conditions do not lend 
themselves to scale up because they may employ risky chemicals, such as phenol and 
chloroform, require the use of large amounts of chromatographic resin per milligram 
of plasmid purified, or necessitate the use of relatively expensive enzymes in order to 
degrade contaminants, for instance, RNase, and the use of some solutions at high 
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production scale would turn into considerable capital investment. Due to their 
simplicity, these purification methods are however the method of choice for 
the purification of small amounts of plasmid DNA (<20 mg) and are extensively used in 
research laboratories (Sambrook and Russell, 2001). 
 
TABLE 3 THE PRINCIPAL APPROVAL SPECIFICATIONS AND RECOMMENDED ASSAYS FOR 
ASSESSING THE PURITY, SAFETY AND POTENCY OF DNA PREPARATIONS FOR GENE THERAPY AND 
DNA VACCINES (ADAPTED FROM FERREIRA ET AL, 2000) 




Bicinchoninic acid (BCA) 
protein assay 
Undetectable 
RNA Agarose-gel electrophoresis Undetectable 
gDNA 
Agarose-gel electrophoresis Undetectable 





lysate (LAL) assay 
< 0.01 EU (µg plasmid)
-1
 
(EU = endotoxin units) 
Plasmid isoforms (linear, 
relaxed, denatured) 
Agarose-gel electrophoresis < 5% 
Biological activity and identity 
Restriction endonucleases 












Back to the main steps of pDNA purification, the first one that raises concern is 
cell lysis. In this step, all the intracellular components, including plasmid DNA, RNA, 
gDNA, endotoxins and proteins, are released. The shear sensitivity of plasmid and 
gDNA molecules, as well as the high viscosity of the lysates, is of major concern during 
plasmid release (Ciccolini et al, 1998; Levy et al, 1999; Prazeres et al, 1999). By far, 
the most common technique used in the production of plasmid DNA is alkaline lysis. 
This procedure relies on the use of sodium hydroxide and the detergent sodium dodecyl 
sulfate (SDS), which combined effects result in the disruption of the cell membrane, 
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leading to lysis and release of the intracellular components. Subsequent neutralization 
with sodium acetate precipitates protein and genomic DNA. Upon neutralization, 
supercoiled plasmid DNA stabilize from its pH-denatured state while large molecular 
weight (~200 kb) genomic DNA cannot diffuse and anneal properly, resulting in single-
stranded genomic DNA precipitation. In addition, at high pH, RNA degrades, which 
benefits downstream separation steps. However, this lysis is rather delicate as plasmid 
DNA can be degraded at high pH if high shear conditions are produced during this 
procedure, and some of the supercoiled DNA could be converted to alternative forms 
(denatured supercoiled, multimeric, open circle, and linear). 
 
 
FIGURE 2 LARGE-SCALE PLASMID DNA PURIFICATION STEPS. EACH IMPORTANT STEP LISTED 
WITH THE CHOICES (LEFT) AND SCALE-UP ISSUES (RIGHT) FOR EACH APPLICABLE TECHNOLOGY 
(ADAPTED FROM PRATHER ET AL, 2003) 
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Following alkaline-lysis, a precipitate is formed that contains cell debris, 
denatured proteins and nucleic acids, and this must be removed. This might be 
accomplished by using any solid–liquid unit operation provided that low shear forces 
are used. Centrifugation on fixed-angle rotors is the most common operation at the 
laboratory and preparative scales. In large-scale production, filtration is the best option 
(Ferreira et al, 1999; Marquet et al, 1995; Prazeres et al, 1998; Theodossiou et al, 
1997). 
 Subsequent steps, clarification and concentration, are designed to remove 
remaining proteins and host nucleic acids, which are usually removed by „salting out‟ 
using a high concentration of chaotropic salts (Chakrabarti et al, 1992; Horn et al, 
1995). Plasmid DNA is commonly concentrated using polyethylene glycol (PEG) 
precipitation after the clarification step in order further to remove small nucleic acids 
and to reduce the volume of process streams before adsorption purification. PEG 
precipitation also enables a buffer exchange, preparing the plasmid extracts for the next 
purification step (Ferreira et al, 2000). 
To purified sc pDNA, liquid chromatography is the method of choice. The size 
and chemical properties of the target nucleic acid molecules (charge and 
hydrophobicity), the accessibility of the nucleotide bases to ligands, and the topological 
constraints imposed by supercoiling are exploited via the interaction of nucleic acids 
with solid supports, with the objective of selectively isolating and purifying plasmid 




2.2. CHROMATOGRAPHIC METHODS 
 
 Generally, chromatography can be described as a separation method that is 
accomplished by distributing the substances between the mobile and the stationary 
phases. 
 As said before, liquid chromatography (LC) is the method of choice to purified 
sc pDNA. LC consists in a separation of mixture components between two phases: the 
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mobile phase, which is liquid and moves in a specific direction, and the stationary phase 
(Sewell et al, 2000). This separation can be based in size, charge, hydrophobicity or 
affinity of the component that needs to be purified relatively to the stationary phase. 
Main chromatographic techniques applied to pDNA purification are: size-
exclusion, ion-exchange, hydrophobic interaction, reversed-phase, thiophilic adsorption 
and affinity, either as an isolated step or integrated in an overall purification process 
(Sousa et al, 2008). 
As said before, LC can be support by size, charge, hydrophobicity or affinity. 
The methods used in this project are charge and hydrophobicity-related, but a table with 
all types (table 4) is given below. 








Reversed-phase liquid chromatography 
Reversed-phase ion-pair chromatography 
Hydrophobic interaction chromatography 
Thiophilic adsorption chromatography 
Affinity-related 
Triple-helix affinity chromatography 
Protein–DNA affinity chromatography 
Immobilised metal affinity chromatography 
Boronate affinity chromatography 
Polymyxin B affinity chromatography 
Note: at bold are adsorptions used in this project. 
Before describing hydrophobic and anion-exchange chromatographic methods, it 
is important to describe the limitations of these techniques when applied to pDNA 
purification. These limitations are due the physical and chemical similarities between 
impurities and pDNA that result in poor selectivity due to competition or co-elution of 
impurities in pDNA pools; however this can be improved by reducing impurity load 
prior to chromatography. Other problem is the high viscosity of feed solutions that 
increase pressure drop and decreased linear flow rates and throughput, but this could be 
circumvent by avoiding small beads, dilute feed streams or use expanded beds. At last, 
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chromatography purification can be limited by the large pDNA size, large size of high 
Mr RNA and small pore size, leading to small diffusion coefficients (so poor internal 
mass transfer), large peaks (low recovery), small flow rates (long separation times) and 
poor capacity for pDNA due to lack of accessibility, that can be solved by pDNA 
compaction, bead size decrease, use of beads with “superpores” or “tentacles”, use 
formats such as membrane layers and monoliths, pre-digestion of high Mr RNA with 
RNase and use micropellicular stationary phases (Diogo et al, 2005). One of the most 
reported drawbacks of pDNA chromatography is poor capacity of stationary phases for 
pDNA binding, and that is why is important the development of new stationary phases, 
the major aim of this project (chapter 3) (Diogo et al, 2005). 
  
 
2.3 HYDROPHOBIC INTERACTION ADSORPTION 
 
Hydrophobic interaction chromatography (HIC) is a well-established 
bioseparation technique in laboratory and industrial scale protein purification. HIC 
explores the interaction between immobilized hydrophobic ligands and non-polar 
regions of, for example, a protein surface in a non-denaturing environment (Queiroz et 
al, 2001). These interactions are promoted mainly by van der Waals forces (Van Oss et 
al, 1986) and the underlying mechanisms have been described using different 
approaches such as the solvophobic theory (Melander et al, 1984; Diogo et al, 2002) 
and preferential interaction theory (Arakawa et al, 1982). HIC is entropy driven process, 
driven by the release and rearrangement of water molecules that occur during, for 
example, protein adsorption to the stationary phase (Janson and Rydén, 1998). 
The mechanism for HIC adsorption is quite complex and depends on a number 
of process parameters, including the temperature, pH, salt concentration, adsorbent 
ligand density, and adsorbent ligand hydrophobicity. The salt type chosen is 
determinant for the separation success of HIC, the one usually chosen is ammonium 
sulfate (at 1,0M - 2,4M concentrations) due to its high salting-out ability, high solubility 




HIC purifies plasmids on the basis of the differences in the hydrophobicity of 
pDNA and impurities. RNA and denatured gDNA, which are essentially single stranded 
molecules, have a high hydrophobic character due to the exposure of their hydrophobic 
bases, whereas pDNA molecules typically present a low hydrophobicity, since the 
majority of the bases are shielded inside the double helix. Consequently, pDNA can be 
purified with negative HIC by loading feed solutions at a high concentration of an 
adequate salt and subsequently performing step or gradient elution with low salt to 
remove bound impurities (Deshmukh and Lali, 2005; Diogo et al, 2000; Diogo et al, 
2001; Li et al, 2005). But the retention time could be a problem in HIC and affect DNA 
isoforms separation; could induce a partial denaturation of the double helix at AT rich 
spots, leads to the exposure of the bases to the ligands, so to an increase in the 
hydrophobic interaction strength. This hypothesis is consistent with the observation that 
single-stranded oligonucleotides bind more tightly to reverse-phase and hydrophobic 
interaction matrices than duplex DNA fragments of the same length (Colote et al, 1986; 
Diogo et al, 2000; Huber, 1998). 
One of the widely used stationary phases on HIC is sepharose CL-6B 
derivatised. Experiments carried out with Sepharose CL-6B derivatised with a mildly 
hydrophobic ligand (1,4-butanediol diglycidyl ether), proved that is possible to separate 
native sc pDNA from the more hydrophobic nucleic acid impurities (RNA, gDNA, 
oligonucleotides, denatured pDNA) under non-denaturing conditions and in the 
presence of 1,5M of ammonium sulphate (explained by the fact that pDNA molecules 
have the hydrophobic bases packed and shielded inside the double helix, and thus, the 
hydrophobic interaction with the HIC media is minimal, whereas single stranded 
nucleic acids impurities show a higher exposure of the hydrophobic bases, and thus, 
interact with the hydrophobic ligands). Sepharose CL-6B derivatised with 1,4-
butanediol diglycidyl ether was successfully used for the separation of pDNA isoforms 
(in the presence of 1,5M of ammonium sulphate), so has also been used analytically for 
the monitoring and control of pDNA quality. Other cellulose and sepharose based HIC 
materials have also been found to promote the binding of poly A, denatured DNA or 







2.4. ANION-EXCHANGE ADSORPTION 
 
Ion-exchange chromatography (IEC) is one of the most commonly used methods 
for downstream recovery of biomaterials. Although this process is based essentially on 
the interactions between charged biomaterials and charged resins, hydrophobic and 
other non-specific interactions may also be involved, with increased salt concentration 
the ion shield reduced the electrostatic attraction and retention volume in the column, on 
the other hand, as the salt concentration raises to reaches a specific threshold, retention 
volume increases with the salt concentration. The advantages of this technique are rapid 
separation, no solvent requirement, decontamination with sodium hydroxide and a wide 
selection of process-grade stationary phases (Eon-Duval and Burke, 2004; Melander et 
al, 1989). 
 Particularly, in pDNA purification, the separation is based on the interaction 
between DNA negatively charged phosphate groups and positively charged ligands on 
the stationary phase (Prazeres et al, 1998). The polyanionic structure of nucleic acids 
can be exploited by IEC, because the overall charge of nucleic acids depends on the 
number of bases that make up the molecule (one negative charge per base), the expected 
elution profiles follow the order of increasing molecular size, but it also could be 
sequence dependent. A salt gradient is employed to displace the different nucleic acids 
that should elute in order of increasing charge density, a property, which in turn is a 
function of chain length and conformation. In some cases, base sequence and 
composition affect the elution pattern of nucleic acids in anion exchangers. Several 
inversions in retention time as a function of chain length were attributed to a higher AT 
content of the more retarded molecule (as said before, hydrophobic interactions may be 
involved) (Huber, 1998; Prazeres et al, 2001; Sinden, 1994; Yamakawa, 1996). 
When using AEC to separate pDNA, the clarified lysate feed should always be 
loaded at a sufficiently high salt concentration (typically >0.5M NaCl) to avoid an 
unnecessary adsorption of low charge density impurities, such as low Mr RNA, 
oligonucleotides and proteins. Under these conditions, a significant amount of 
impurities elute in the flow through and capacity can be fully exploited for pDNA 
adsorption. Molecules with a high charge density, such as pDNA isoforms, high Mr 
RNA and gDNA are retained and subsequently eluted by increasing the ionic strength of 
the mobile phase. Many AEC stationary phases display poor separation selectivity 
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towards pDNA and impurities due to their similar binding affinities. This lack of 
selectivity makes purification of pDNA very difficult to achieve in a single AEC step. 
In most cases a second chromatographic step is needed to meet the required purity or 
pre-purification steps are required (Colpan and Riesner, 1984; Eon-Duval and Burke, 
2004; Ferreira et al, 2000; Prazeres et al, 1999). 
Q-Sepharose has been extensively used for AEC of pDNA too. This strong anion 
exchanger is made of 6% highly cross-linked agarose particles derivatised with 
quaternary amino groups. A comparison of the performance of Mono Q- and Hi-load Q-
Sepharose columns on the small and large-scale purification of pDNA showed that both 

























CHAPTER 3. MATRICES AS STATIONARY PHASE 
 
As said before, one of the major problems in plasmid purification is the 
stationary phase capacity. So, there are a great interest in explore alternative matrices 
that could be modified and applied to plasmid adsorption. As plasmids are large 
molecules, is newsworthy to give special attention to micro and nano-particles based-
matrices. The polymers used to produce these matrices were cellulose, a natural one, 
and polyvinyl alcohol, a synthetic one.  
A technique of growing interest, and the one used to fabricate the PVA 
nanofibers used in this project, is electrospinning, whose important advantages are the 
production of very thin fibers to the order of few nanometers with large surface areas, 
simplicity of functionalization for various purposes, superior mechanical properties and 
ease of process. The possibility of large scale productions combined with the simplicity 
of the process makes this technique very attractive for many different applications (like 






Nanofibers have very small diameters, large surface area per unit mass and small 
pore size, making them interesting candidates for a wide variety of applications, such as 
templates (Liu, 2004; Sun et al, 2003), reinforcement (Bergshoef and Vancso, 1999; 
Kim and Reneker, 1999), filtration (Yoon et al, 2006; Ma et al, 2005), catalysis (Stasiak 
et al, 2007; Chen et al, 2007), biomedical and pharmaceutical applications (Welle et al, 
2007; Cui et al, 2006; Luu et al, 2003) and electronic and optical devices (Choi et al, 
2003; Kim and Yang, 2003; Wang et al, 2002). Properties such as strength, weight, 
porosity and surface functionality can be manipulated, depending on the polymer used. 
Furthermore, small insoluble particles can be added to the polymer solution and 
encapsulated in the dry nanofibers (Frenot and Chronakis, 2003). 
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The major purpose of nanofibers application in purification processes is benefit 
from an increased surface area, because specific surface area increases as dimensions 
decrease, in other words, a higher proportion of atoms is on the surface. 
There are a few different methods to produce nanofibers, including, for example, 
phase separation (Ma and Zhang, 1999) and drawing (Ondarçuhu and Joachim, 1998), 






Electrospinning, or electrostatic spinning, is a novel process for forming fibers 
with submicron scale diameters through the action of electrostatic forces (Fong and 
Reneker, 2001). While conventional fiber spinning techniques are capable of produce 
polymer fibers with diameters down to micrometer range, electrospinning is capable of 
produce fibers in the nanometer diameter range, including diameters lower than 100nm 
(Frenot and Chronakis, 2003). 
Electrospinning was first described as a fabrication technology by Rayleigh in 
1897 (Burger et al., 2006), studied in more detail by Zeleny in 1914 (Zeleny, 1914) and 
patented by Formhals in 1934 (Formhals, 1934). However, it only has been applied in 
nanotechnology in 1990 and since then, an increasing number of studies have shown 
that a large variety of polymers can be electrospun (Reneker and Chun, 1996). 
Electrospinning has substantial adaptability for processing a variety of polymers 
with possible control of the fiber fineness (Greiner and Wendorff, 2007; Jayaraman et 
al, 2004; Li and Xia, 2004; Reneker and Chun, 1996), orientation (Li et al, 2003), 
surface morphology (Casper et al, 2004) and bicomponent cross-sectional configuration 
(Lin et al, 2005; Sun et al, 2003). 
In general, in electrospinning, a high electric potential is applied to a polymer 
solution (majority) or melt. The fibers are derived by charging a liquid typically to 5-30 
kV versus a ground a short distance away, which leads to charge injection into the 
liquid from the electrode. The sign of the injected charge depends on the polarity of the 
electrode, so a negative electrode produces a negatively charged liquid. The charged 
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liquid is attracted to the ground electrode of opposite polarity, forming a Taylor cone at 
the nozzle orifice as the polymer solution is drawn out by the electric field to form a 
liquid jet. As the solvent of the polymer jet evaporates, the jet solidifies and a polymer 
fiber is formed. In the past decade, substantial attention was drawn to electrospinning 
with research interests focusing on the theoretical foundation of the electrospinning 
process, including fiber initiation, jet instability, and the structure and morphology of 
the electrospun fibers (Deitzel et al, 2001; Fong et al, 1999; Reneker and Chun, 1996; 
Shin et al, 2001; Yarin et al, 2001; Yarin et al, 2001
2
). A general scheme of 





FIGURE 3 GENERAL SCHEME OF ELECTROSPINNING DEVICE [DC = DIRECT CORRENT] (ADAPTED 
FROM YAO ET AL, 2003) 
 
 
Essentially, an electrospinning consists of three major components: a high-
voltage power supply, a spinneret and an electrically conductive collector. For most 
experiments, an ordinary hypodermic metallic needle and a piece of aluminum foil work 
well as the spinneret and the collector, respectively (Li et al, 2006). 
There is only one procedure to electrospinning, but there are several nanofibers 
collectors, so it is possible to obtain different types of nanofibers, depending on the end 
use of resultant nanofibers. The most commons are: a cylinder collector with high 
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rotating speed (the one represented at figure 3), an auxiliary electrode/electrical field, a 
thin wheel with sharp edge and a frame collector. The collector design and the 
nanofibers structure obtained are represented at table 5. 
 
 
TABLE 5 TYPES OF COLLECTORS AND FIBERS ALIGNEMENT (ADAPTED FROM HUANG ET AL, 2003) 
CYLINDER COLLECTOR WITH HIGH ROTATING SPEED 
It has been suggested that by rotating a cylinder collector at a very high speed up to thousands 
of rpm, electrospun nanofibers could be oriented circumferentially (Boland et al, 2001; 
Matthews et al, 2002). 
 
 
AUXILIARY ELECTRODE/ELECTRICAL FIELD 
Deposited fibers can be circumferentially oriented substantially by employing an auxiliary 
electrical field. The alignment effect with and without the auxiliary electrical fields can be seen 







THIN WHEEL WITH SHARP EDGE 
The tip-like edge substantially concentrates the electrical field so that the nanofibers are almost 
all attracted to and can be continuously wound on the bobbin edge of the rotating wheel. The 
distance between two fibers can varied from 1 to 2 μm; before reaching the electrically 





Another approach to fiber alignment can be by simply placing a rectangular frame structure 





As said before, there are a number of factors that can be controlled in 
electrospinning, but there are several external parameters and processing variables that 
affect the electrospinning process: system parameters such as molecular weight, 
molecular weight distribution and architecture (branched, linear etc.) of the polymer and 
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solution properties (viscosity, conductivity and surface tension), and process parameters 
such as electric potential, flow rate and concentration, distance between the capillary 
and collection screen, ambient parameters (temperature, humidity and air velocity in the 
chamber) and finally motion of target screen (Wilkes, 2001). For instance, the polymer 
solution must have a concentration high enough to cause polymer entanglements yet not 
so high that the viscosity avoids polymer motion induced by the electric field. The 
solution must also have a surface tension low enough, a charge density high enough, 
and a viscosity high enough to prevent the jet from collapsing into droplets before the 
solvent has evaporated. Morphological changes can occur upon decreasing the distance 
between the syringe needle and the substrate. Increasing the distance or decreasing the 
electrical field decreases the bead density, regardless of the concentration of the 
polymer in the solution (Deitzel et al, 2001). 
 
 
3.2. CELLULOSE FIBERS 
 
Cellulose is a naturally occurring polymer of great interest, because of its 
abundant availability, biodegradability, compatibility with biological systems and low 
non-specific binding when used during purification. It consists of a linear polymer of 
1,4 β-D-glucose (fig. 4). Cellulose fibers are useful in wide range areas, such as 
filtration, biomedical applications and protective clothing (Zhang et al, 2008, Cuculo et 
al, 2001). There has been growing interest in the use of cellulose in chromatographic 
techniques, because it provides an interesting spectrum of geometrical and 
morphological forms, the support is relatively inexpensive and the raw material is 
renewable (Gemeiner et al, 1998). 
 
 
FIGURE 4 MOLECULAR STRUCTURE OF CELLULOSE 
22 
 
Cellulose-based media displays the characteristics for an ideal matrix: a high 
specificity, the absence of hydrophobic binding sites (hydrophilic), good chemical 
stability (neutral and stable under storage and operational conditions), good mechanical 
rigidity, high binding capacity (contain functional groups to allow attachment of the 
affinity ligands), good recoverability, high reproducibility and low cost. However, there 
is main objection against cellulose-based affinity adsorbents; they may exhibit 
nonspecific adsorption (Aniulyte et al, 2006; Clonis, 1987; Groman et al, 1987; Liu et 
al, 1994; Narayanan et al, 1990). 
 
 
3.3. POLYVINYL ALCOHOL FIBERS 
 
 
Polyvinyl alcohols (PVA) are synthetic polymers used since the early 1930s in a 
wide range of industrial, commercial, medical and food applications including resins, 
lacquers, surgical threads and food-contact applications (DeMerlis and Schoneker, 
2003). 
 PVA empirical formula is (C2H4O)n(C4H6O2)m and has a molecular weight 
between 30,000 and 200,000 g/mol, is water soluble and is insoluble in aliphatic and 
aromatic hydrocarbons, esters, ketones and oils. Physically, in general, PVA is an 
odorless white to cream-colored granular powder (Handbook Pharm. Excip., 1994; 
Japan. Pharm. Excip. Dir., 1996). 
The physical characteristics of PVA are dependent on its method of preparation 
from the hydrolysis, or partial hydrolysis, of polyvinyl acetate (fig. 5), being classified 
as partially hydrolyzed or fully hydrolyzed (DeMerlis and Schoneker, 2003). 
 
 




 PVA has already been used to make anion-exchange membranes, prepared 
through a reaction with quaternary ammonium groups, but this was meant to be applied 
in a completely different area of purification processes; was made for alkaline direct 
methanol fuel cell applications (Xiong et al, 2008). So, its application to pDNA 
































CHAPTER 4. PURPOSE AND FUNDAMENTAL 
RESEARCH QUESTIONS  
 
 As said before, one of the major problems in plasmid purification is the 
stationary phase capacity. So, the main achievement of this experimental research is to 
find alternative matrices to pDNA purification, regarding to economical, simple and 
efficacy features. 
 The choice of cellulose is due their easy and cheap obtainment and their 
relatively trouble-free modification; sepharose was mainly to compare results.  
 At the beginning, the aim was to produce cellulose nanofibers from cellulose 
pulp solution by electrospinning, but that was not possible to accomplish. Since good 
results about sepharose derivatized are known and cellulose has a similar structure, 
cellulose derivatized microfibers were test with the possibility to be a better matrix than 
sepharose, with two types of adsorption: hydrophobic interaction (is the most common 
and is easy and low-cost to perform) and anion-exchange (is also easy and low-cost and, 
generally, is more effective). 
 Back to the major intend, due the higher surface capacity, the study of 
nanofibers is indispensable. The electrospun nanofibers sample was send from 
Cincinnati, Ohio, USA, but it was a small sample and the polymer used was PVA. Due 
the polymer structure and small amount, PVA nanofibers are going to be modified only 
to carry out anion-exchange adsorption. 
The method of choice is batch adsorption, because of possible problems like 
column chromatography high back pressure (due the small particles sized stationary 
phase) and poor capacity pDNA binding (due pDNA large size), furthermore is an 
easier method to scale-up. 
  So, the fundamental research question is: how those matrices behave in plasmid 
DNA purification? The approaches how to answer this question are represented 








1. Fermentaion of E.coli DH5α transformed 
with plasmid pVAX1-LacZ
2. Cellular lysis and purification of supercoild 




3. Quantification of ligand binding
Pure sc pDNA Polymer derivatized
Gel capacity by amount of ligands
pDNA adsorption uptake kinetics
 
FIGURE 6 GENERAL RESEARCH PLAN. ACCORDING TO THE TYPES OF POLYMER AND 
















Hydrophobic interaction cellulose 
microfibers modification
1. Pre-treatment: ultrasounds
2. Derivatization: Activation with 1,4-
butanediol diglycidyl ether
Epoxy-cellulose
Determination of amount of ligands by 
tritation
pDNA adsorption in batch with buffer 






2. Derivatization: Activation with Glycidyl 
trimethyl ammonium chloride
Cationic-cellulose
Determination of amount of ligands by 
SEM analysis
pDNA adsorption in batch with buffer 




Anion-exchange sepharose gel 
modification
2. Derivatization: Activation with Glycidyl 
trimethyl ammonium chloride
Q-Sepharose
Determination of amount of ligands by 
SEM analysis
pDNA adsorption in batch with buffer 
tris-Cl 10mM + 1MEDTA + 0,5M 
sodium chloride
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Anion-exchange PVA nanofibers 
modification
1. Pre-treatment: with methanol
2. Derivatization: Activation with Glycidyl 
trimethyl ammonium chloride
Cationic-PVA
Determination of amount of ligands by 
SEM analysis
pDNA adsorption in batch with buffer 




FIGURE 7 MODIFICATIONS GENERAL PROCEDURE SKETCH OF: A. CELLULOSE MICROFIBERS TO 
HYDROPHOBIC INTERACTION; B. CELLULOSE MICROFIBERS TO ANION-EXCHANGE; C. CL-6B-




CHAPTER 5. EXPERIMENTAL PLASMID DNA 
PRODUCTION 
 
5.1. E. COLI FERMENTATION 
 
The 6,05 kpb plasmid pVAX1-LacZ (Invitrogen, Carlsband, CA, USA) used in 
the experiments was produced by a cell culture of Escherichia coli DH5α. 
Globally, growth was carried out at 37°C in a bioreactor with 250 mL of Terrific 
Broth (table 6) supplemented with 30 μg/mL kanamycin. The dissolved oxygen 
concentration was kept at 30% of saturation, and growth was suspended at the late log 
phase (OD600 ≈ 8). 
Cells were recovered by centrifugation and stored at −20°C. 
 






Tryptone - 12 g/L 
Yeast extract - 24 g/L 
Glycerol M=92,10g/mol 4 mL/L 














                                               
1
 solution 10 times more concentrated that the one is needed is prepared and stored, previously. 
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5.1.1. E.COLI INOCULATION 
 
The solutions, LB-Agar and TB media, and all the required material were 
autoclaved previously. 
Petri dishes with LB-Agar with kanamycine were prepared to inoculate the cells. 
Escherichia coli DH5α transformed with plasmid pVAX1-LacZ was inoculated and 




A few bacterial colonies that grew overnight were inoculated in 62,5 mL of TB 
media with 30 μg/mL kanamycin. The suspension were kept under rotation (250 rpm), 
at 37ºC, until a OD600 ≈ 2,6 was reached. 
 
TABLE 7 SAMPLE ABSORBENCIES DURING PRE-FERMENTATION 
Time (h) Absorbency’ Dilution Absorbency 
1,0 0,457 None 0,457 
2,5 0,939 1:2 1,878 
3,0 0,638 1:4 2,552 
Final (3,1) 0,684 1:4 2,736 
 
The volume used to carry out the fermentation was calculated through the 
following formula: 
                                                          2 
 
So, the pre-fermentation suspension volume was 9,842 mL to each 125 mL of 
fermentation broth. 
                                               
2 ODpre-ferment = pre-fermentation suspension optic density; 
Vpre-ferment = pre-fermentation suspension volume; 
ODferment = fermentation suspension optic density (0,2); 





Fermentation suspensions (already with kanamycin and pre-fermentation 
suspension) were kept under rotation (250 rpm), at 37ºC, until a OD600 ≈ 8,0 was 
reached. The absorbency was measured hour by hour, in the beginning, just to see how 
E.coli population grows (tables 8 and 9). 
 The growth was stopped with centrifugation. The suspensions were transferred 
to falcons that were centrifuged 15 min, at 4ºC and 5000g. Then, supernatant was 
discarded and cells pellet was frozen at -20ºC. 
 
TABLE 8 SAMPLE A ABSORBENCIES DURING FERMENTATION 
Time (h) Absorbency’ Dilution Absorbency 
1,0 0,555 None 0,555 
2,0 0,701 1:2 1,402 
3,0 0,433 1:5 2,165 
4,0 0,536 1:5 2,680 
Overnight 
19,0 0,765 1:10 7,65 
20,0 0,770 1:10 7,70 
 
TABLE 9 SAMPLE B ABSORBENCIES DURING FERMENTATION 
Time (h) Absorbency’ Dilution Absorbency 
1,0 0,549 None 0,549 
2,0 0,698 1:2 1,396 
3,0 0,427 1:5 2,135 
4,0 0,562 1:5 2,810 
Overnight 
19,0 0,768 1:10 7,68 
20,0 0,786 1:10 7,86 
 
 
The procedure was repeated, several times, with a few changes: the tryptone 
mass measured was 6,25g (instead of 3,858g) – but only samples C and D –, the 
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centrifuge velocity used, at the end, to precipitate de pellet was 4500 rot/min (instead of 
5000 rot/min) and the absorbency measure hour by hour was no long performed – all. 
The tryptone mass used at the first time is the one that is currently used at the laboratory 
(concentration of 12g/L) and the second is the one that is indicated at the papers 
(concentration of 20g/L). The centrifuge velocity alteration was due the finding that 
4500 rot/min is sufficient to precipitate the cells. The absorbencies after pre-
fermentation and fermentation as the volume needed to carry out fermentations are at 
annex A. 
 
5.2. CELLULAR LYSIS AND PLASMID DNA PURIFICATION WITH 
QIAGEN® KIT 
 
QIAGEN Plasmid Purification Kits are based on the selectivity of patended 
QIAGEN Resin, allowing purification of ultrapure supercoiled plasmid DNA with high 
yields. 
QIAGEN plasmid purification protocols are based on a modified alkaline lysis 
procedure, followed by binding of plasmid DNA to QIAGEN Anion-Exchange Resin 
under appropriate low-salt and pH conditions. RNA, proteins, dyes, and low-molecular-
weight impurities are removed by a medium-salt wash. Plasmid DNA is eluted in a 
high-salt buffer and then concentrated and desalted by isopropanol precipitation 
(QIAGEN Plasmid Purification Handbook 11/2005). 





Agarose gel electrophoresis was performed to analyzed pDNA yield and quality. 
To do that, were saved four aliquots from different steps of pDNA purification 




TABLE 10 FRACTIONS SAVED FOR AGAROSE GEL ELECTROPHORESIS 
Sample id. Fraction Volume (L) Contain 
1 Cleared lysate 120 
sc and oc pDNA and 
degraded RNA 
2 Flow-through 120 only degraded RNA 
3 
Buffer QC wash 
fractions 
240 completely clear 
4 Buffer QF/QN elute 60 Pure pDNA 
 
 Figure 8 shows the analytical gel of the different steps fractions from two 
performances of QIAGEN kit pDNA purification (A and B). The lanes identification 










TABLE 11 LANES IDENTIFICATION AND RESULTS ANALYSIS 
Lane Identification Analysis 
1 A1 Cleared lysate containing sc and oc pDNA and degraded RNA, as expected 
2 A2 
Flow-through containing the same impurities that A1, but it was supposed to be only 
degraded RNA  after the first step, the sample still have a high impurities degree  
3 A3 Buffer QC wash fractions completely clear, as expected 
4 A4 Buffer QF/QN elute with pDNA and a light contamination of genomic DNA 
5 B1 Same as A1 
6 B2 Same as A2  
7 B3 Same as A3 
8 B4 Buffer QF/QN elute with pure pDNA 
 
 
5.4. RECOVER OF ANION-EXCHANGE RESINS FOR PLASMID DNA 
PURIFICATION 
 
After elution of plasmid DNA following the procedures suggested by the 
manufacturer, the tips were washed briefly with deionized water to remove any 
particulate materials that are trapped on top of the packed resins and salt deposits on the 
outer surface of the tips before storage. 
Immediately before applying the used tips for plasmid DNA purification, 10 mL 
of “renew” buffer (3M NaCl, 0,15% Triton X-100) is added into the tips and allowed to 
flow through to remove any residual material from the previous use. This process was 
repeated three times (Chang et al, 1999). 
 







M = 58, 443 
g/mol 
3 M 




CHAPTER 6. EXPERIMENTAL MATRICES PRODUCTION 
 
Cellulose fibers origin: 
Pine cellulose pulp obtained by Kraft method was used as a source for the 
microfibrillated cellulose. The pulp was treated in three steps: a refining step to increase 
the accessibility of the cell wall to the subsequent monocomponent endoglucanase 
treatment, an enzymatic step and a second refining. 
Cellulose pulp was torn into small pieces (a portion corresponding to 360,6g of 
dry cellulose) and wetted in 4L of distilled water. After 3 hours, the cellulose 
suspension was mechanically refined using a Valley Beater Rafiner to 27ºSR. Cellulose 
pulp thus obtained was seeped out by filtration and homogenized in Karl Frank 
Homogenizer. Next, the enzyme was added. In this enzymatic treatment, 360,6g 
(calculated as dry fibers) of the refined pulp was dispersed in 9L of phosphate buffer 
(pH 7, final pulp concentration 4%(w/w)) with 0,11 μL of monocomponent 
endoglucanases per gram dry fiber and then incubated for 2 hours at 50ºC. The mixture 
was stirred manually every 30 minutes. Then, the samples were washed with 30L of 
deionized water, drained and homogenized. The monocomponent endoglucanase was 
denaturated by heating at 80ºC for 30 minutes and then the pulp sample was washed 
with 20 liters of deionized water. The pre-refined and enzyme treated pulp was refined 
once again with the Valley Beater, this time, to 92ºSR (Szewczyk, 2009). 
The cellulose fibers (not yet in a micro scale range) that Katarzyna Szewczyk 
obtained were stored in a solution of water with 20% ethanol, at 4ºC. 
 
 
6.1. ULTRASONIC TREATMENT  
 
First of all, a pre-wash step was performed to remove ethanol from samples. 
Samples were washed by a centrifuge method: washing with water, five rounds of 1min, 






TABLE 13 SAMPLES VOLUMES AFTER PRE-WASH STEP 
Sample A1 A2 A3 A4 B1 B2 B3 B4 
Volume 
(mL) 
22,0 22,0 24,0 22,0 27,5 27,0 25,0 27,0 
 
 
Samples were treated with ultrasounds (Labsonic P B Braun Biotech Intern., 
amplitude 80, cycle 0,5), during 30 minutes, with a break of 30 seconds in every 
minute, to not overheating and homogenize the sample. The initial and final 
temperatures of fibers were measured (Table 14). 
 
TABLE 14 TEMPERATURES OF THE SAMPLES BEFORE AND AFTER ULTRASONIC TREATMENT 
Sample A1 A2 A3 A4 B1 B2 B3 B4 
Initial temp. 
(ºC) 
25,0 25,5 25,0 25,0 24,0 24,5 26,0 26,5 
Final temp. 
(ºC) 
76,0 73,0 74,0 72,0 78,0 76,0 74,0 73,0 
 
The samples were stored, at 4ºC, in a solution of water with 20% ethanol, until 












6.2. MODIFICATION OF CELLULOSE MICROFIBERS TO 
HYDROPHOBIC INTERACTION ADSORPTION  
 
The protocol used for this step was based on Sundberg‟s (Sundberg and Porath, 
1974). The list of reagents is at table 15. 
 







diglycidyl ether  




M = 40 g/mol 
99% pure 
R35, S26, S45, 
S37/39 
0,6 M and 1 M 
Sodium borihydride 








M = 36,46 g/mol 
37% pure 
d = 1,19 






Per gram of cellulose microfibers gel, the sample was mixed with 1 mL of 1,4-
butanediol diglycidyl ether and 1 mL of 0,6 M sodium hydroxide solution containing 2 
mg of sodium borihydride per milliliter (figure 9). The suspension was mixed by 
rotation for 8 hours at 25ºC and the reaction stopped by washing the gel with large 
volumes of water with the centrifuge-wash method. The amounts used are described in 
table 16. 
After washing, to determine the amount of bound substance (step 6.1.2.2), were 
retired 500 mg samples and the rest of the gel was placed in 1M NaOH overnight, to 




FIGURE 9 REACTION OF POLYMER ACTIVATION (ADAPTED FROM SUNDBERG AND PORATH, 1974) 
 
TABLE 16 SAMPLES AND REAGENTS USED IN THE ACTIVATION STEP 
Sample 
Identification (HI)I 
Primary sample A2, A3 and A4 









Sodium hydroxide 0,6 M 
50,0 
50,0 







Sodium hydroxide 0,6 M 
1,22 
1,23 














After 24h with 1M NaOH, the cellulose microfibers gel was washed with a great 




6.2.2. EPOXY GROUPS QUANTIFICATION 
 
The epoxy groups are quantified through a typical titration method. To each 500 
mg sample was added 5 mL of water and 15 mL of 1,3 M sodium thiosulphate. Until a 
pH = 7 was reached 0,01 M hydrochloric acid was added (figure 10). The initial and 
final pH were measured (table 17). 




With the HCl volume and the weight of dry gel samples is possible to quantify 














Initial pH Final pH 
0,01 M HCl vol. 
(mL) 
I 
Ia 11,79 7,07 0,60 
Ib 11,86 6,33 1,20 




                                               
3 This period was extended to 96 hours due the observation of water in the sample. 
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TABLE 18 DRY GEL SAMPLES WEIGHT AND AMOUNT OF LIGANDS IN GEL SURFACE 
Sample 
Dry gel mass* 
(g) 
Amount of H 
(µmol) 
Amount of ligands 
(µmol/g) 
Ia 0,349 6,00 17,192 
16,808 Ib 0,173 12,00 69,364 
Ic 0,274 4,50 16,423 
Note: The sample in grey was excluded to calculate the gel capacity. 
*the samples weight was obtained by subtracting falcons mass from falcons with dry gel mass. 
 
Other gel samples were prepared with the same procedure as the first one, with 
one only exception: gels III, IV and V were titrated with HCl 0,005 M.  The amount 
differences were in the surface modification step and are tabulated at annex C. 
 
 
6.3. MODIFICATION OF CELLULOSE MICROFIBERS TO ANION-
EXCHANGE ADSORPTION  
 
The protocol used for this step was based on Hjertén‟s (Hjertén et al, 1991). The 
list of reagents is at table 19. 
 
TABLE 19 SURFACE MODIFICATION PROTOCOL REAGENTS 
Reagents Information available Concentration required 
Glycidyltrimethyl-
ammonium chloride 
M = 151,63 g/mol 
D=1,13 g/mL 
R45, R60, R20/21/22, 
R48/22, R68, R41, R43, 
R52/53, S53, S26, 
S36/37/39, S45, S61 
m = 70g 
Sodium hydroxide 
M = 40,0 g/mol 
99% pure 
R35, S26, S45, S37/39 
0,5 M 
Sodium borihydride 






Per 2 grams of cellulose microfibers gel, the sample was mixed with 2 mL of 0,5 
M sodium hydroxide solution containing 40 mg of sodium borihydride per milliliter and 
2mL of 2,3-epoxypropyl-trimethyl ammonium chloride (figure 11). The suspension was 
maintained under rotation (90 rpm) for 3 days at 25ºC and the reaction stopped by 
washing the gel with large volumes of water with the centrifuge-wash method. The 
amounts used are described at table 20. 
 
 
FIGURE 11 REACTION OF POLYMER ACTIVATION (ADAPTED FROM SMITHT ET AL.,  2007) 
 
 
TABLE 20 SAMPLES AND REAGENTS USED IN THE ACTIVATION STEP 
Sample 
Identification AE-Cel-I 
Primary sample B4 
Mass 10,009 g 
Sodium hydroxide 
Concentration required 0,5 M 
Volume prepared 50,0 mL 
Mass 1,01 g 
Volume needed 10,0 mL 
Sodium borihydride Mass required 0,202 g 
Glycidyltrimethyl-ammonium 
chloride 
Mass required 6,0 g (d = 1,13) / 2g 
Volume measured 26,5 mL 
 
After washing, the sample was stored, at 4ºC, in a solution of water with 20% 
ethanol. Other gel samples were prepared with the same procedure as the first one; the 







6.4. MODIFICATION OF CL-6B-SEPHAROSE TO ANION-EXCHANGE 
ADSORPTION  
 
 This matrix was prepared from commercial CL-6B Sepharose (Sepharose™ CL-
6B apbiotech, lot 287614). 
A pre-wash step was performed to remove ethanol from samples (centrifuge 
method). 
The protocol used for this step is the same used for cellulose (step 6.3.). The 
only thing that differs is the amounts (table 21). 
 
TABLE 21 SAMPLES AND REAGENTS USED IN THE MODIFICATION 
Sample 
Identification AE-Sep-I 
Primary sample Commercial 
Mass 20,004 g 
Sodium hydroxide 
Concentration required 0,5 M 
Volume prepared 50,0 mL 
Mass 1,01 g 
Volume needed 20,0 mL 
Sodium borihydride Mass required 0,402 g 
Glycidyltrimethyl-ammonium 
chloride 
Mass required 6,0 g (d = 1,13) / 2g 
Volume measured 53,1 mL 
 
After washing, the sample was stored, at 4ºC, in a solution of water with 20% 
ethanol. Other gel samples were prepared with the same procedure as the first one; the 
amounts used are at annex D too. 
 
6.5. MODIFICATION OF PVA NANOFIBERS TO ANION-EXCHANGE 
ADSORPTION  
 
 The first step was to immerse the poly(vinyl) alcohol nanofibers in methanol, for 
3 days, to dissolve and form a relatively homogeneous solution (like gel), but that did 




The protocol used for the modification is similar to the one used for cellulose 
(step 6.3.), differing the amounts (table 22). 
During the 3 days suspension (under rotation), at 25ºC, nanofibers packed and 
took a very rigid and inflexible consistency, even after the wash step. 
The sample was stored, at 4ºC, in a solution of water with 20% ethanol. 
This was the only performance of PVA nanofibers modification. 
 
TABLE 22 SAMPLES AND REAGENTS USED IN THE MODIFICATION 
Sample 
Identification PVA 
Primary sample PVA nanofibers electrospun 
Mass 1,52 g 
Sodium hydroxide 
Concentration required 0,5 M 
Volume prepared 50,0 mL 
Mass 1,01 g 
Volume needed 1,52 mL 
Sodium borihydride Mass required 0,0304 g 
Glycidyltrimethyl-ammonium 
chloride 
Mass required 6,0 g (d = 1,13) / 2g 




6.6. SCANNING ELECTRON MICROSCOPY 
  
A scanning electron microscope (SEM) operates in such a way that an electron 
beam having a fine spot, by being finely focused, is used to scan the surface of a 
specimen in its longitudinal and lateral directions and reflected electrons, or secondary 
electrons emitted from points of the specimen bombarded by the primary electron beam, 
are detected in the form of signals, which signals are then supplied to a cathode-ray 
tube, which is scanned in synchronized relation with the above scanning by the primary 
electron beam, so as to modulate brightness of the cathode-ray tube and to thereby 




 The analysis with SEM is made to realize the microfibers and nanofibers size 
and identified the atoms on the matrices surface, to find out if modification was succeed 
and the degree of substitution. 
 A minimum amount of samples were placed in lamellas and dried, to remove all 
humidity, then were coated with gold (deposited by vacuum), to protect the sample of 


















































FIGURE 21 Q-SEPHAROSE MODIFIED BY US FOR ANION-EXCHANGE, MAGNIFICATION X500 
 
 




6.6.2. ELEMENTAL ANALYSIS 
 







Another sample of 
microfibers modified 
Sample B1 Sample (HI)II Sample (HI)I 
C 79,3 51,68 66,91 
O 16,52 30,58 22,41 
Al - 0,85 - 
Si 1,38 11,59 6,66 
Ag 0,32 0,34 0,40 
K 0,59 1,72 1,07 
Ca - - - 
Au 1,39 1,14 1,41 
N - - - 
Na - 0,85 0,30 
Cl 0,36 - - 
Ti - 0,65 0,41 

























Sample B4 Sample AE-Cel-I 
C 74,12 61,21 
O 23,39 20,56 
Al - 1,03 
Si 0,45 3,38 
Ag 0,40 0,40 
K - 0,75 
Ca - 0,71 
Au 1,65 1,42 
N* - 9,72 
Na - - 
Cl - 0,49 
Ti - - 
Zn - 0,32 
*with large margin of error 
 














C 75,74 59,38 55,98 
O 23,15 18,44 28,46 
Al - - 3,51 
Si 0,47 0,27 - 
Ag - - 0,29 
K - - - 
Ca - - - 
Au 0,65 1,10 0,86 
N* - 11,31 10,48 
Na - 0,29 - 
Cl - 8,96 - 
Ti - - - 
Zn - 0,24 - 
*with large margin of error 
50 
 

































CHAPTER 7. PLASMID DNA ADSORPTION TRIALS 
 
7.1. HYDROPHOBIC INTERACTION WITH EPOXY-CELLULOSE 
MATRIX 
 
To study hydrophobic interaction between pDNA and the epoxy-cellulose gel 
was used a high concentration of ammonium sulfate and the reaction lasts 24 hours 
(steps 7.1.2. and 7.1.3.). Just to verify that these conditions are good choices, others 
conditions experiments were performed (step 7.1.1.). 
As said before, after activation, gel was stored in a solution of water with 20% 
ethanol, at 4ºC. So, before execute adsorptions assessments, a pre-wash step was 
performed: samples were washed with water and centrifuged (1min, 4600rpm), 5 rounds 
each. 
 
7.1.1. OPTIMIZATION AND CONTROL EXPERIMENTS 
 
 First of all, it was made a study to find out the best reaction time and to verify 
the salt concentration influence. 
The reaction takes place in eppendorfs with modified gel (about 50mg) and 200 
µL of pDNA or control (only buffer with or without salt) solution. Those eppendorfs 
were kept in a 25ºC bath, with rotation, and an absorbency reading was made, after 8, 
12 and 24 hours. 
The data presented in table 27 are already a summary of the results obtained, 










TABLE 27 CONTROL EXPERIMENT 


















  Tris-Cl 10 mM (pH = 8.0) 
Salt  

   

  Ammonium sulfate 3 M 




  0, 150 mg / mL 
 
8 hours 0,006 0,062 0,124 0,023 The presence of salt is determinant for HI. 
Most of the interaction happens in the first 
hours, but still occurs in 24hours. 
12 hours 0,012 0,037 0,115 0,018 




7.1.2. EPOXY-CELLULOSE BATCH ADSORPTION IN AMMONIUM SULFATE 
3.0 M 
 
 The reaction takes place in buffer tris-Cl 10 mM (pH = 8.0) with 3M ammonium 
sulfate. Reagents needed to prepare the solution are at table 28. 
 
















Were prepared samples with different pDNA concentrations from the “stock 
sample” stored at -80ºC, after QIAGEN kit purification (step 5.2), and buffer tris-Cl. 
The samples concentrations were selected with a maximum diversity in the possible 
range, but the actual concentrations not equalize theoretical (table 29), because samples 
were prepared in a way to use maximum possible initial sample (higher concentrations), 
since it was so small. 
53 
 
The reaction takes place in eppendorfs with modified gel (about 50mg) and 
200µL of pDNA solution (or control). Those eppendorfs were kept in a 25ºC bath, with 
rotation, and an absorbency reading was made, after 24 hours. 
The first time that this experiment was performed, the theoretical concentrations 
were 75, 150 and 500µg/mL (two times each). Data it is describe at table 30. 
  







75 0,0785 78,5 
150 0,1610 161,0 
500 0,5335 533,5 
 
 












(µg pDNA/ Kg 
gel) 
78,5 52,5 11,0 13,5 257142,86 
161,0 52,0 13,5 29,5 567307,69 
533,5 51,0 456,5 15,4 301960,78 
 
 
 Other adsorption tests valid results are summarized at table 31. Those data 























(µg pDNA/ mg 
gel) 
33,0 48,0 12,0 4,2 0,0875 
91,0 51,0 8,0 16,6 0,3255 
106,0 48,0 41,0 13,0 0,2708 
239,0 51,0 148,0 18,2 0,3569 
239,0 52,0 155,0 16,8 0,3231 
285,0 50,0 219,0 13,2 0,264 
285,0 49,0 191,0 18,8 0,3837 
388,0 53,0 304,0 16,8 0,3170 
423,0 56,0 341,0 16,4 0,2928 
423,0 51,0 353,0 14,0 0,2745 
452,0 54,0 378,0 14,8 0,2741 
452,0 56,0 368,0 16,8 0,3000 
520,0 58,0 458,0 12,4 0,2138 





7.1.3. EPOXY-CELLULOSE BATCH ADSORPTION IN AMMONIUM SULFATE 
2.0 M 
 
This study procedure is like 7.1.2., but with a lower salt concentration. It was 
made to decrease the consumption of salt, but, in fact, to guarantee a good hydrophobic 
interaction, 2,0 M ammonium sulfate are insufficient. The maximum adsorption was 









The reaction takes place in buffer tris-Cl 10 mM (pH = 8.0) with 1M EDTA and 
0,5 M NaCl. Reagents needed to prepare the solution are at table 32. 
 
TABLE 32 PDNA ANION-EXCHANGE ADSORPTION PROTOCOL REAGENTS 




M = 121,14 g/mol 






Sodium chloride M = 58, 443 g/mol 0,5 M 
 
Were prepared samples with different pDNA concentrations from the “stock 
sample” stored at -80ºC, after QIAGEN kit purification (step 5.2), and buffer tris-Cl. 
The samples concentrations were selected with a maximum diversity in the possible 
range. 
The reaction takes place in eppendorfs with modified gel (about 30mg) and 
200µL of pDNA solution (or control). These eppendorfs were kept in a 25ºC bath, with 
rotation, and absorbencies readings were made after 24hours or at time (in hours) 4, 8, 
20, 24, 28, 32 (two different study types). 
Data of those experiments are described at tables 33 and 34 and are analyzed in 




















(µg pDNA/ mg 
gel) 
33,0 42,9 23,0 2,0 0,0466 
33,0 42,6 23,0 2,0 0,0469 
33,0 44,2 15,0 3,6 0,0814 
93,0 29,7 33,0 12,0 0,4040 
93,0 27,2 22,0 14,2 0,5220 
93,0 32,1 24,0 13,8 0,4299 
145,0 24,5 16,0 25,8 1,0531 
145,0 31,4 21,0 24,8 0,7898 
145,0 36,1 17,0 25,6 0,7091 
252,0 47,3 36,0 43,2 0,9133 
252,0 33,5 27,0 45,0 1,3433 
252,0 25,2 36,0 43,2 1,7143 
479,0 33,0 104,0 75,0 2,2727 
479,0 30,3 153,0 65,2 2,1518 





























(µg pDNA/ mg 
gel) 
Time = 4 hours 
17,0 19,9 14,0 0,6 0,0302 
17,0 36,7 15,0 0,4 0,0109 
121,0 52,1 23,0 19,6 0,3762 
121,0 29,5 28,0 18,6 0,6305 
121,0 40,9 19,0 20,4 0,4988 
167,0 50,5 17,0 30,0 0,5941 
167,0 46,6 30,0 27,4 0,5880 
Time = 8 hours 
17,0 49,1 10,0 1,36 0,0278 
17,0 19,9 3,0 2,73 0,1372 
121,0 52,1 34,0 16,96 0,3256 
121,0 29,5 28,0 18,14 0,6147 
121,0 40,9 29,0 17,94 0,4386 
167,0 50,5 30,0 26,72 0,5290 
167,0 46,6 26,0 27, 50 0,5900 
Time = 20 hours 
17,0 49,1 13,0 0,76 0,0155 
17,0 19,9 12,0 0,95 0,0477 
121,0 52,1 16,0 19,95 0,3829 
121,0 40,9 12,0 20,71 0,5064 
167,0 50,5 18,0 28,31 0,5606 
167,0 37,8 14,0 29,07 0,7690 
167,0 46,6 30,0 26,03 0,5586 
Time = 24 hours 
17,0 36,7 11,0 1,11 0,0302 
121,0 29,5 16,0 19,42 0,6585 
121,0 40,9 11,0 20,35 0,4976 
167,0 50,5 17,0 27,75 0,5495 
167,0 37,8 21,0 27,01 0,7146 
167,0 46,6 12,0 28,68 0,6153 
Time = 28 hours 
17,0 19,9 12,0 0,90 0,0452 
17,0 36,7 16,0 0,18 0,0049 
121,0 52,1 33,0 15,84 0,3040 
121,0 29,5 23,0 17,64 0,5980 
121,0 40,9 31,0 16,20 0,3961 
167,0 50,5 45,0 21,96 0,4348 
167,0 46,6 39,0 23,04 0,4944 
Time = 32  hours 
17,0 19,9 13,0 0,70 0,0352 
121,0 52,1 44,0 13,48 0,2586 
121,0 29,5 38,0 14,52 0,4924 
121,0 40,9 43,0 13,65 0,3337 
167,0 50,5 77,0 15,75 0,3119 
167,0 37,8 76,0 15,92 0,4213 
167,0 46,6 49,0 20,65 0,4431 
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7.3. ANION-EXCHANGE INTERACTION WITH Q-SEPHAROSE 
MATRIX (OUR MODIFICATION) 
 
 Those studies have an identical procedure to the ones described at 7.2. (at 
laboratory, most of those assays were done at the same time). The results are described 
at tables 35 and 36 and discuss in chapter 8. 












(µg pDNA/ mg 
gel) 
33,0 43,2 20,0 2,6 0,0602 
33,0 44,2 29,0 0,8 0,0181 
33,0 27,1 31,0 0,4 0,0148 
93,0 36,3 25,0 13,6 0,3746 
93,0 36,0 28,0 13,0 0,3611 
93,0 19,8 53,0 8,0 0,4040 
145,0 46,0 32,0 22,6 0,4913 
145,0 51,8 47,0 19,6 0,3784 
145,0 24,2 75,0 14,0 0,5785 
252,0 36,5 170,0 16,4 0,4493 
252,0 30,8 162,0 18,0 0,5844 
252,0 48,0 152,0 20,0 0,4167 
479,0 24,5 392,0 17,4 0,7102 
479,0 31,7 402,0 15,4 0,4858 























(µg pDNA/ mg 
gel) 
Time = 4 hours 
17,0 39,4 13,0 0,8 0,0203 
17,0 44,8 10,0 1,4 0,0312 
121,0 49,2 61,0 12,0 0,2439 
121,0 32,0 72,0 9,8 0,3062 
121,0 31,0 103,0 3,6 0,1161 
167,0 41,5 95,0 14,4 0,3470 
167,0 40,9 105,0 12,4 0,3032 
Time = 8 hours 
17,0 34,3 14,0 0,58 0,0171 
17,0 39,4 13,0 0,78 0,0198 
121,0 49,2 54,0 13,06 0,2655 
121,0 32,0 81,0 7,80 0,2438 
121,0 31,0 66,0 10,72 0,3460 
167,0 41,5 64,0 20,08 0,4840 
167,0 40,9 72,0 18,52 0,4529 
167,0 37,4 81,0 16,77 0,4484 
Time = 20 hours 
17,0 34,3 14,0 0,57 0,0166 
121,0 49,2 21,0 19,00 0,3862 
121,0 32,0 41,0 15,20 0,4750 
121,0 31,0 36,0 16,15 0,5210 
167,0 41,5 33,0 25,46 0,6135 
167,0 40,9 71,0 18,24 0,4460 
167,0 37,4 52,0 21,85 0,5842 
Time = 24 hours 
17,0 34,3 13,0 0,74 0,0216 
17,0 39,4 13,0 0,74 0,0188 
121,0 49,2 23,0 18,13 0,3685 
121,0 32,0 25,0 17,76 0,5550 
121,0 31,0 36,0 15,72 0,5072 
167,0 41,5 30,0 25,34 0,6107 
167,0 40,9 40,0 23,50 0,5744 
167,0 37,4 32,0 24,98 0,6678 
Time = 28 hours 
17,0 34,3 11,0 1,08 0,0315 
121,0 49,2 19,0 18,36 0,3732 
121,0 31,0 34,0 15,66 0,5052 
167,0 41,5 20,0 26,46 0,6360 
167,0 40,9 33,0 24,12 0,5897 
167,0 37,4 25,0 25,56 0,6834 
Time = 32 hours 
17,0 34,3 11,0 1,05 0,0306 
121,0 49,2 45,0 13,30 0,2703 
121,0 32,0 74,0 8,22 0,2570 
167,0 41,5 54,0 19,78 0,4765 
167,0 37,4 62,0 18,38 0,4913 
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7.4. ANION-EXCHANGE INTERACTION WITH Q-SEPHAROSE 
MATRIX (COMMERCIAL) 
 
The buffer used in these interaction is also tris-Cl 10 mM (pH = 8.0) with 1M 
EDTA and 0,5 M NaCl. 
Were prepared samples with different pDNA concentrations from the “stock 
sample”, stored at -80ºC after QIAGEN kit purification (step 5.2), and buffer tris-Cl. 
The reaction takes place in eppendorfs with commercial gel (about 30mg) and 200µL of 
pDNA solution (or control). Those eppendorfs were kept in a 25ºC bath, with rotation, 
and absorbencies readings were made after 24hours. 
Data of those experiments are described at table 37 and are analyzed in chapter 8 
(discussion). 
 












(µg pDNA/ mg 
gel) 
66,0 51,0 32,0 6,8 0,1333 
66,0 53,0 24,0 8,4 0,1585 
114,0 53,0 66,0 9,6 0,1811 
114,0 53,0 61,0 10,6 0,2000 
140,0 51,0 79,0 12,2 0,2392 
140,0 48,0 83,0 11,4 0,2375 
172,0 50,0 103,0 13,8 0,2760 
172,0 51,0 109,0 12,6 0,2471 
222,0 60,0 121,0 20,2 0,3367 
404,0 56,0 245,0 31,8 0,5678 






CHAPTER 8. DISCUSSION  
 
8.1. MATRICES MODIFICATION 
 
 The first step was an ultrasonic treatment of cellulose fibers to guarantee a range 
of micrometers (or nanometers, if possible). Through SEM analysis were detected 
microfibers with a diameter from 6 to 30 micrometers (figures 12-19).  
Then, was performed a modification of the cellulose microfibers surface to 
hydrophobic interaction. The best degree of ligand substitution detected by titration was 
76,733 μmol/g (annexes table V). By elemental analysis, it is possible to calculate 
degree of substitution (DS) through the following equation: 
                  
                 
    
 
        
      
       4 
Was not possible to calculate the DS for cellulose sample modified to 
hydrophobic interaction (comparing samples B1 with (HI)II) because of the Si 
contamination (11,59% detected), results in a negative value, so it is disregarded. Doing 
the calculation with samples B1 and (HI)I, results in a DS of 1.6, which is a good result, 
assuming that the primary sample of (HI)I is similar to the primary sample of (HI)II. 
About the Si contamination, it comes from cover glass (possibly been scraped during 
sample preparation) (table 23).  
The same happens for the samples modified to anion-exchange adsorption, both 
cellulose and sepharose gels, because of Si and Cl contaminations. Cl contamination 
comes from a poor wash of the sample, after modification. But, besides the large margin 
of error, it is considered that the modification was succeeding due to detection of atom 
N (tables 24 and 25). 
As said before, during the modification procedure, PVA nanofibers packed and 
took a very rigid and inflexible consistency, even after the wash step. Was not possible 
                                               
4
 DS = degree of substitution  
%Cgel derivatized = percentage of Carbon in the gel sample after modification 
%Cgel derivatized = percentage of Carbon in the gel sample before modification 
%Cgel derivatized = percentage of Carbon in the ligand 
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to analyze the structure in SEM, because is in a nanometer range, and elemental 
analysis revealed that the degree of ligand substitution was very low or inexistent (N 




8.2. PDNA ADSORPTION 
 
 Through hydrophobic interaction was possible to adsorb up to 0,4 μg of pDNA 
per mg of gel, with ammonium sulfate 3,0 M  (figure 23). As said before, an enormous 
concentration of salt was needed, so the hydrophobic interaction may be due the amount 





FIGURE 23 HYDROPHOBIC INTERACTION EPOXY-CELLULOSE BATCH: ADSORPTION ISOTHERM 
(AFTER 24HOURS) 
 
 Through anion-exchange batch, the results were much better as expected. 
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Adsorption over time experiments were performed with modified cellulose and 
sepharose gels to study how pDNA is adsorbed and to identify the best reaction time. 
Those experiments were made only with low pDNA initial concentration, because was 
not possible to purified higher pDNA quantities (at this time of master‟s research, was 
no longer possible to produce high concentrations and the factor was not identify). For 




FIGURE 24 ANION-EXCHANGE CELLULOSE BATCH: ADSORPTION OVER TIME (FOR PDNA INITIAL 
CONCENTRATION OF 17, 121 AND 167 µg/mL) 
 
 
FIGURE 25 ANION-EXCHANGE Q-SEPHAROSE BATCH: ADSORPTION OVER TIME (FOR PDNA 
INITIAL CONCENTRATION OF 17, 121 AND 167 µg/mL) 
64 
 
In both cellulose and sepharose tests, is visible a decrease of adsorption after 25 
hours of reaction, the possible explanations for this are: a full binding capacity of gel 
and starts to loose adsorption capacity, a destruction of gel because of the time exposure 
to buffer or a modification of pDNA structure that induces inaccuracy of the results. 
In the 24 hours experiment with anion-exchange matrices, it was possible to use 
a bigger range of pDNA concentration, from 33,0 to 479,0 μg/mL. In cellulose based 
matrix, the adorption was up to 2,5 μg of pDNA per mg of gel, and there is a possibility 
that this adsorption can be higher with an enhanced of pDNA concentration (figure 26). 
Comparing with sepharose based-matrix (figure 27), cellulose microfibers are a better 
support, due to surface area expose to ligands. 
A commercial anion-exchange support was tested too to compare with the 
matrices modified by us. By the same conditions, anion-exchange commercial Q-
sepharose and Q-sepharose modified have a similar capacity adsorptive, although is 
possible that commercial Q-sepharose have a slightly higher capacity, but it was not 
possible do try with higher pDNA initial concentrations (figure 28). 
 
 






FIGURE 27 ANION-EXCHANGE Q-SEPHAROSE BATCH: ADSORPTION ISOTHERM (AFTER 24 HOURS) 
 
 
FIGURE 28 ANION-EXCHANGE COMMERCIAL Q-SEPHAROSE BATCH: ADSORPTION ISOTHERM 












 Through hydrophobic interaction, the adsorption was up to 0,4 μg of pDNA per 
mg of gel, a low gel capacity and probably due the amount of salt used to perform this 
experiment (ammonium sulfate 3,0 M), because with a reduction of salt concentration, 
pDNA adsorption was even lower. 
Through anion-exchange batch, the adorption was up to 2,5 μg of pDNA per mg 
of gel, and there is a possibility that this adsorption can be higher with an enhanced of 
pDNA concentration and/or a decrease of gel mass. Comparing with sepharose based-
matrix (adorption was up to 0,7 μg of pDNA per mg of gel), cellulose microfibers are a 
better support, due to surface area expose to ligands. 
The surface modification to anion-exchange support method used in the research 
is not the ideal to PVA nanofibers, since this modification was not succeed and PVA 
nanofibers structure was altered irreversibly. 
Factors that can be improved in these alternative matrices to pDNA purification 
experiments are: an increase of pDNA initial concentrations, a decrease of gel mass and, 
if possible, an increase of matrix surface area, i.e. a decrease of particle/fibers size. 
So, in the future could be made some improvements, specifically, changes, like 
size decrease, in the structure of cellulose fibers, if it demonstrate certain adsorption 
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ANNEX A - OTHER PERFORMANCES OF PLASMID DNA 
PRODUCTION 
 
ANNEXES TABLE I DATA FROM OTHER FERMENTATIONS 
Sample C 
Pre-fermentation time 3h30min 
Absorbency after pre-fermentation (at 600nm) 3,10 (0,620 with 1:5 dilution) 
Pre-fermentation volume to fermentation 8,621 mL 
Fermentation time 24h 
Absorbency fermentation (at 600nm) 12,90 (0,645 with 1:20 dilution) 
Sample D 
Pre-fermentation time 3h30min 
Absorbency after pre-fermentation (at 600nm) 3,10 (0,620 with 1:5 dilution) 
Pre-fermentation volume to fermentation 8,621 mL 
Fermentation time 24h 
Absorbency fermentation (at 600nm) 14,18 (0,709 with 1:20 dilution) 
Sample E 
Pre-fermentation time 4h 
Absorbency after pre-fermentation (at 600nm) 2,925 (0,585 with 1:5 dilution) 
Pre-fermentation volume to fermentation 9,174 mL 
Fermentation time 24h 
Absorbency fermentation (at 600nm) 7,99 (0,799 with 1:10 dilution) 
Sample F 
Pre-fermentation time 4h 
Absorbency after pre-fermentation (at 600nm) 2,925 (0,585 with 1:5 dilution) 
Pre-fermentation volume to fermentation 9,174 mL 
Fermentation time 24h 
Absorbency fermentation (at 600nm) 6,98 (0,698 with 1:10 dilution) 
Sample G 
Pre-fermentation time 4h30 
Absorbency after pre-fermentation (at 600nm) 5,18 (0,518 with 1:10 dilution) 
Pre-fermentation volume to fermentation 5,02 mL 
Fermentation time 25h 
Absorbency fermentation (at 600nm) 6,37 
Sample H 
Pre-fermentation time 4h30 
Absorbency after pre-fermentation (at 600nm) 5,18 (0,518 with 1:10 dilution) 
Pre-fermentation volume to fermentation 5,02 mL 
Fermentation time 25h 
Absorbency fermentation (at 600nm) 8,15 
Sample I 
Pre-fermentation time 4h30 
79 
 
Absorbency after pre-fermentation (at 600nm) 5,18 (0,518 with 1:10 dilution) 
Pre-fermentation volume to fermentation 5,02 mL 
Fermentation time 25h 
Absorbency fermentation (at 600nm) 9,70 
Sample J 
Pre-fermentation time 4h30 
Absorbency after pre-fermentation (at 600nm) 5,18 (0,518 with 1:10 dilution) 
Pre-fermentation volume to fermentation 5,02 mL 
Fermentation time 25h 
Absorbency fermentation (at 600nm) 9,04 
Sample K 
Pre-fermentation time 3h00 
Absorbency after pre-fermentation (at 600nm) 2,83 (0,518 with 1:10 dilution) 
Pre-fermentation volume to fermentation 9,00 mL 
Fermentation time 25h30min 
Absorbency fermentation (at 600nm) 5,83 
Sample L 
Pre-fermentation time 3h00 
Absorbency after pre-fermentation (at 600nm) 2,83 (0,518 with 1:10 dilution) 
Pre-fermentation volume to fermentation 9,00 mL 
Fermentation time 25h30min 
Absorbency fermentation (at 600nm) 6,95 
Sample M 
Pre-fermentation time 3h00 
Absorbency after pre-fermentation (at 600nm) 2,83 (0,518 with 1:10 dilution) 
Pre-fermentation volume to fermentation 9,00 mL 
Fermentation time 25h30min 
Absorbency fermentation (at 600nm) 5,57 
Sample N 
Pre-fermentation time 3h00 
Absorbency after pre-fermentation (at 600nm) 2,83 (0,518 with 1:10 dilution) 
Pre-fermentation volume to fermentation 9,00 mL 
Fermentation time 25h30min 












ANNEX B – QIAGEN PLASMID MAXI KIT PROCEDURE 
 
ANNEXES TABLE II COMPOSITION OF BUFFERS AND REAGENTS 
Buffer Function Composition 
P1 Resuspension 
50mM Tris-Cl, pH 8,0 
10mM EDTA 
100µg/mL RNase A 
P2 Lysis 200mM NaOH, 1%SDS 
P3 Neutralization 




50 mM MOPS, pH 7,0 
15%isopropanol 
0,15% Triton X-100 
QC Wash 
1,0M NaCl 












QIAGEN kit General Procedure 
with some alterations, signalized in grey 
 
 Add RNase A solution to Buffer P1; 
 Check Buffer P2 for SDS precipitation; 
 Pre-chill Buffer P3 to 4ºC 
Bacterial culture, harvest and lysis 
 Homogeneously resuspend 125mL of bacterial pellet in 10mL Buffer P1; 
 Add 10mL Buffer P2, mix carefully by inverting 4-6 times, and incubate at room 
temperature for 5 min.; 
 Add 10mL Buffer P3, mix carefully by inverting 4-6 times, and incubate in ice 




Bacterial lysate clearing 
 Centrifuge at ≥20.000g for 30min at 4ºC. Re-centrifuge the supernatant at 
≥20.000g for 15min at 4ºC. 
Bind, wash and elute plasmid DNA 
 Equilibrate a QIAGEN-tip by applying 10mL Buffer QBT and allow column to 
empty by gravity flow. 
 Apply the supernatant to the QIAGEN-tip and allow it to enter the resin by 
gravity flow. 
 Wash QIAGEN-tip with 2×30mL Buffer QC. Allow Buffer QC to through thr 
QIAGEN-tip by gravity flow. 
 Elute DNA with 15mL Buffer QF into clean 50mL vessel. 
Precipitate, wash and redissolve plasmid DNA 
 Precipitate DNA by adding 10,5mL room-temperature isopropanol to the eluted 
DNA and mix. Centrifuge at ≥15.000g for 30min at 4ºC. Carefully decant 
supernatant. 














ANNEX C - OTHER PERFORMANCES OF HYDROPHOBIC 
INTERACTION CELLULOSE MATRIX PREPARATION  
 
ANNEXES TABLE III SAMPLES AND REAGENTS USED IN THE ACTIVATION STEP 
Sample 
Identification II III IV 
Primary sample B1 B4 B2 
Mass 
(g) 






























































24,6 25,0 25,8 
Rotation 
(U/min) 




ANNEXES TABLE IV EPOXY GROUPS QUANTIFICATION - SAMPLES PH BEFORE AND AFTER 





Initial pH Final pH HCl vol. (mL) 
II 
IIa 10,83 5,87 0,30 
IIb 11,47 7,07 0,80 
IIc 11,55 7,74 0,85 
III 
IIIa 10,7 7,0 3,2 
IIIb 11,0 7,0 3,1 
IIIc 11,0 7,0 3,6 
IV 
IVa 11,15 7,0 0,75 




ANNEXES TABLE V EPOXY GROUPS QUANTIFICATION – DRY GEL SAMPLES WEIGHT AND 
AMOUNT OF LIGANDS 
Sample 
Dry gel mass 
(g) 





IIa 0,147 3,00 20,408 
48,239 IIb 0,170 8,00 47,059 
IIc 0,172 8,50 49,419 
III 
IIIa 0,344 16,00 46,512 
76,733 IIIb 0,208 15,50 74,519 
IIIc 0,228 18,00 78,947 
IV 
Iva 0,250 3,75 15,000 
15,716* 
IVb 0,213 3,50 16,432 
Note: The samples in grey were excluded to calculate the gel capacity 










ANNEX D - OTHER PERFORMANCES OF ANION-EXCHANGE 
MATRICES PREPARATIONS 
 
ANNEXES TABLE VI SAMPLES AND REAGENTS USED IN THE MODIFICATION (CELLULOSE) 
Sample 
Identification AE-Cel-II AE-Cel-III 
Primary sample B1 A3 e A4 
Mass 0,512 g 0,500 g 
Sodium hydroxide 
Concentration required 0,5 M 0,5 M 
Volume prepared 50,0 mL 50,0 mL 
Mass 1,01 g 1,01 g 
Volume needed 0,50 mL 0,50 mL 
Sodium borihydride Mass required 0,005 g 0,005 g 
Glycidyltrimethyl-
ammonium chloride 
Mass required 6,0 g (d = 1,13) / 2g 6,0 g (d = 1,13) / 2g 
Volume measured 1,327 mL 1,327 mL 
 
 
ANNEXES TABLE VII SAMPLES AND REAGENTS USED IN THE MODIFICATION (SEPHAROSE) 
Sample 
Identification AE-Sep-II AE-Sep-III 
Primary sample Commercial Commercial 
Mass 0,505 g 0,506 g 
Sodium hydroxide 
Concentration required 0,5 M 0,5 M 
Volume prepared 50,0 mL 50,0 mL 
Mass 1,01 g 1,01 g 
Volume needed 0,50 mL 0,50 mL 
Sodium borihydride Mass required 0,005 g 0,005 g 
Glycidyltrimethyl-
ammonium chloride 
Mass required 6,0 g (d = 1,13) / 2g 6,0 g (d = 1,13) / 2g 





















































ANNEXES FIGURE VII ANION-EXCHANGE Q-SEPHAROSE BATCH: ADSORPTION ISOTHERM 
(AFTER 4 HOURS) 
 
 
ANNEXES FIGURE VIII ANION-EXCHANGE Q-SEPHAROSE BATCH: ADSORPTION ISOTHERM 








ANNEXES FIGURE IX ANION-EXCHANGE Q-SEPHAROSE BATCH: ADSORPTION ISOTHERM 
(AFTER 20 HOURS) 
 
 









ANNEXES FIGURE XI ANION-EXCHANGE Q-SEPHAROSE BATCH: ADSORPTION ISOTHERM 
(AFTER 28 HOURS) 
 
 
ANNEXES FIGURE XII ANION-EXCHANGE Q-SEPHAROSE BATCH: ADSORPTION ISOTHERM 
(AFTER 32 HOURS) 
 
